# OVATIO CRT and SITUS OTW LV Lead Post Approval Study

> **NCT00795873** · — · COMPLETED · sponsor: **ELA Medical, Inc.** · enrollment: 2260 (estimated)

## Conditions studied

- Heart Failure

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00795873
- **Lead sponsor:** ELA Medical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 2260 (ESTIMATED)
- **Last updated:** 2013-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00795873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00795873, "OVATIO CRT and SITUS OTW LV Lead Post Approval Study". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT00795873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*